Intco Medical Technology Co., Ltd.
300677
Helyezés a részvények között
#3957
Intco Medical Technology Co., Ltd. is a company dedicated to the development,... Intco Medical Technology Co., Ltd. is a company dedicated to the development, manufacturing, and worldwide distribution of both single-use medical products and durable medical equipment, serving markets within China and internationally. Their extensive product portfolio includes a variety of personal protective equipment like gloves, face masks, and shields, as well as essential clinical supplies such as ECG electrodes, medical apparel (e.g., isolation gowns), and hand hygiene solutions in both gel and spray forms. The company also produces specialized surgical components, including grounding pads, electrosurgical pencils, ESU cables, tip cleaners, and TENS electrodes. Beyond disposables, Intco Medical supplies a range of robust medical devices, notably mobility aids such as wheelchairs and scooters, along with other general medical apparatus. Their offerings further extend to temperature therapy items, emergency treatment provisions, products for maternal and infant care, and various home healthcare solutions. Established in 2009 and headquartered in Zibo, China, the company underwent a formal corporate name update in January 2020, maintaining its designation as Intco Medical Technology Co., Ltd.
Részvényárfolyam
$6.36
Piaci kapitalizáció
$4.16B
Változás (1 nap)
-0.12%
Változás (1 év)
8.75%
Ország
CN
Kereskedés Intco Medical Technology Co., Ltd. (300677)
Kategória
Healthcare
Intco Medical Technology Co., Ltd. (300677) nyeresége
Nyereség ekkor: Jun 2026 TTM: $215.90M
Intco Medical Technology Co., Ltd. legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi nyeresége $215.90M. 2023 évben a vállalat $62.56M nyereséget ért el, csökkenés a 2022 év nyereségéhez, amely $102.12M volt. Az ezen az oldalon megjelenített nyereség a kamatok és adók előtti eredmény, azaz EBIT.
Intco Medical Technology Co., Ltd. nyereségtörténete 2013 és 2026 között
Nyereség az év végén
| Év | Nyereség | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $215.90M | -2.05% |
| 2024 | $220.43M | 252.36% |
| 2023 | $62.56M | -38.74% |
| 2022 | $102.12M | -92.50% |
| 2021 | $1.36B | 6.50% |
| 2020 | $1.28B | 4,276.77% |
| 2019 | $29.19M | -2.81% |
| 2018 | $30.04M | 20.00% |
| 2017 | $25.03M | 77.48% |
| 2016 | $14.10M | 23.57% |
| 2015 | $11.41M | 89.37% |
| 2014 | $6.03M | 240.50% |
| 2013 | $1.77M | 0.00% |
Hasonló cégek vagy versenytársak nyeresége
| Vállalat | Nyereség | Nyereségkülönbség | Ország |
|---|---|---|---|
| $3.81B | 1,662.73% |
US
|
|
| $4.11B | 1,803.09% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | 636.44% |
US
|
|
| - | - |
CH
|
